Helicos BioSciences (HLCS) Names Lowy as CEO
More News related to HLCS
- Helicos BioSciences Provides Strategic Update
- Helicos BioSciences (HLCS) Comments on Q3 Operations
- Helicos BioSciences Q3 2009 Operating Highlights and Strategic Update
- Helicos (HLCS) Receives $1000 Award From the National Human Genome Research Institute
- Helicos BioSciences Receives $1000 Genome Award
More News related to Management Changes
- Morgan Stanley Upgrades CHU to Overweight, Downgrades CHL, CHA to Equal Weight
- Goldman Sachs Upgraded Questar Corp. (STR) to Buy
- Avondale Securities Upgrades J.B. Hunt Transport (JBHT) to Outperform
- BMO Capital Upgrades Suncor Energy (SU) to Outperform
- MF Global Upgrades ArcelorMittal (MT) to Buy
Helicos BioSciences (NASDAQ: HLCS) announced today that its Board of Directors has appointed Ronald Lowy as the company's CEO, effective immediately.
Helicos BioSciences Corporation, a life sciences company, engages in the development of genetic analysis technologies for the research, drug discovery, and clinical diagnostics markets.
Related Categories
Management ChangesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
